This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB03047/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03047/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03047/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03047/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03047
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03047 n13:DB03047
dcterms:title
L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine
adms:identifier
n8:EPH n9:46936564 n10:DB03047 n11:46504534
n3:IUPAC-Name
n4:271B49EF-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B49F5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B49F4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B49F1-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B49F2-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B49F3-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B49ED-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B49EE-363D-11E5-9242-09173F13E4C5 n4:271B49EB-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B49EC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B49FB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B49FC-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B49F6-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B49F7-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B49F9-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B49F8-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B49FA-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4A01-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4A03-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4A04-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4A00-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B49FF-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4A02-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B49F0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B49FD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B49FE-363D-11E5-9242-09173F13E4C5